PLAY PODCASTS
Ivabradine Fails to Prevent Post-Surgery MINS 09/01/25
Episode 14

Ivabradine Fails to Prevent Post-Surgery MINS 09/01/25

Welcome to Cardiology Today – Episode recorded on September 01, 2025. Your source for the latest cardiology research findings from top medical journals. Listen to This Episode Your browser does not support the audio element.

Cardiology Today · Deconstructed Cardiology

September 1, 20250

Audio is streamed directly from the publisher (podcast.explainheart.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Welcome to Cardiology Today – Episode recorded on September 01, 2025. Your source for the latest cardiology research findings from top medical journals.

Listen to This Episode

Your browser does not support the audio element.

Episode Summary

This episode covers 1 recent cardiology research articles published in leading journals including NEJM, JACC, Circulation, European Heart Journal, and Nature Reviews Cardiology.

Featured Research Articles

Article 1: Ivabradine in Patients Undergoing Noncardiac Surgery: a Randomized Controlled Trial.

Journal: Circulation

PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40884771

Summary: This randomized controlled trial investigated ivabradine, a selective heart rate lowering agent, in patients undergoing noncardiac surgery to prevent myocardial injury after noncardiac surgery. The study found no significant reduction in myocardial injury after noncardiac surgery with ivabradine compared to placebo in patients aged 45 years or older with or at risk of atherosclerotic disease. These findings do not support routine use of ivabradine for prevention of myocardial injury after noncardiac surgery.

Full Episode Transcript

Today’s date is September 01, 2025. Welcome to Cardiology Today. Here are the latest research findings.

Article number one. Ivabradine in Patients Undergoing Noncardiac Surgery: a Randomized Controlled Trial. This randomized controlled trial investigated ivabradine, a selective heart rate lowering agent, in patients undergoing noncardiac surgery to prevent myocardial injury after noncardiac surgery. The study found no significant reduction in myocardial injury after noncardiac surgery with ivabradine compared to placebo in patients aged 45 years or older with or at risk of atherosclerotic disease. These findings do not support routine use of ivabradine for prevention of myocardial injury after noncardiac surgery.

Thank you for listening to Cardiology Today.

Keywords

Medical Topics: Cardiology, Cardiovascular Medicine, Heart Disease, Clinical Research, Medical Education, Evidence-Based Medicine

Journals: New England Journal of Medicine (NEJM), Journal of American College of Cardiology (JACC), Circulation, European Heart Journal, Nature Reviews Cardiology

About Cardiology Today

Cardiology Today provides concise, professional summaries of cutting-edge cardiovascular research for healthcare professionals, medical students, and cardiology enthusiasts. Each episode features the latest findings from top-tier medical journals, delivered in an accessible format perfect for staying current with advances in cardiac care.

Subscribe to stay updated with the latest cardiology research • Share with colleagues • Follow for more medical content

The post Ivabradine Fails to Prevent Post-Surgery MINS 09/01/25 first appeared on Cardiology Today.